시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 헤모글로빈 A1c(HbA1c) 검사 시장 보고서(2025년)
Hemoglobin A1c (HbA1c) Testing Global Market Report 2025
상품코드 : 1825759
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

헤모글로빈 A1c(HbA1c) 검사 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 10.4%로 30억 1,000만 달러로 성장할 것입니다. 예측 기간의 성장은 생활습관병 유병률 증가, 예방적 헬스케어에 대한 관심 증가, 신흥 시장에서의 확대, 맞춤형 의료 및 환자 중심 치료의 증가, 규제 지원 및 상환 정책, 원격의료의 확대, 원격 모니터링 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 기술 발전, 디지털 헬스 플랫폼과의 통합, 비침습적 검사 기술의 발전, 원격의료의 확대, 원격 환자 모니터링 등이 있습니다.

향후 5년간 10.4%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 스웨덴과 캐나다에서 개발된 고성능 액체 크로마토그래피(HPLC) 분석기 및 HbA1c 검사 키트의 가격을 급등시켜 혈당 조절 평가의 지연과 내분비학 검사 비용 상승을 초래하여 당뇨병 관리에 지장을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

당뇨병 유병률의 증가는 헤모글로빈 A1c(HbA1c) 검사 시장의 확대를 견인할 것으로 예상됩니다. 당뇨병은 인슐린 분비 부족이나 인슐린 저항성으로 인해 신체가 혈당 조절에 어려움을 겪는 만성질환입니다. 당뇨병 환자의 증가는 식습관, 특히 가공식품과 설탕이 들어간 음료의 과다 섭취, 신체활동이 적고 앉아서 생활하는 생활습관 등의 요인에 기인합니다. 또한, 고령화와 유전적 소인이 당뇨병 발병 가능성을 높이고 있습니다. HbA1c 검사는 지난 2-3개월간의 평균 혈당치를 측정하여 장기적인 혈당 조절을 모니터링하는 데 필수적인 검사입니다. 예를 들어, 2023년 6월 Lancet지 데이터에 따르면, 전 세계 당뇨병 환자는 2021년 5억 2,900만 명에서 2050년 13억 명으로 증가할 것으로 예측됩니다. 그 결과, 당뇨병 유병률의 증가는 HbA1c 검사 시장의 성장을 촉진할 것으로 보입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Hemoglobin A1c (HbA1c) testing measures the percentage of hemoglobin with glucose attached, providing an indication of average blood glucose levels over the past 2 to 3 months. It is used to monitor long-term glucose control in diabetic patients and to diagnose diabetes and prediabetes.

The main types of HbA1c testing are laboratory-based testing and point-of-care (PoC) testing. Laboratory-based testing is conducted in a lab setting where blood samples are analyzed using advanced equipment. Product types for this testing include instruments, reagents, kits, and technologies. These technologies encompass immunoassays, chromatography, enzymatic assays, boronate affinity chromatography, high-performance liquid chromatography, and others. End users of HbA1c testing include hospitals and clinics, diagnostic laboratories, homecare settings, and other medical environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hemoglobin A1c (HbA1c) testing market research report is one of a series of new reports from the business research company that provides hemoglobin A1c (HbA1c) testing market statistics, including hemoglobin A1c (HbA1c) testing industry global market size, regional shares, competitors with an hemoglobin A1c (HbA1c) testing market share, detailed hemoglobin A1c (HbA1c) testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin A1c (HbA1c) testing industry. This hemoglobin A1c (HbA1c) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin a1c (hba1c) testing market size has grown rapidly in recent years. It will grow from $1.83 billion in 2024 to $2.02 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, growing awareness and screening programs, growing government initiatives and healthcare policies, increasing healthcare infrastructure development, a growing aging population, improved diagnostic accuracy, and increased adoption of point-of-care testing.

The hemoglobin a1c (hba1c) testing market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising prevalence of lifestyle diseases, increased focus on preventive healthcare, expansion in emerging markets, increasing personalized medicine and patient-centric care, regulatory support and reimbursement policies, growing telemedicine, and remote monitoring. Major trends in the forecast period include technological advancements, integration with digital health platforms, advancements in non-invasive testing technologies, expansion in telehealth, and remote patient monitoring.

The forecast of 10.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder diabetes management by inflating prices of High-Performance Liquid Chromatography(HPLC) analyzers and point-of-care HbA1c test kits developed in Sweden and Canada, resulting in delayed glycemic control assessments and higher endocrinology testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the hemoglobin A1c (HbA1c) testing market. Diabetes is a chronic condition where the body struggles to regulate blood glucose levels due to inadequate insulin production or insulin resistance. The rise in diabetes cases is attributed to factors such as poor diet-particularly high consumption of processed foods and sugary drinks-and sedentary lifestyles with minimal physical activity. Additionally, the aging population and genetic predisposition increase the likelihood of developing diabetes. HbA1c testing is essential for monitoring long-term blood glucose control by measuring average blood sugar levels over the past 2-3 months. For example, data from The Lancet in June 2023 projected that global diabetes cases would grow from 529 million in 2021 to 1.3 billion by 2050. Consequently, the increasing prevalence of diabetes will fuel the growth of the HbA1c testing market.

Leading companies in the HbA1c testing market are concentrating on developing automated analyzers, such as those using high-performance liquid chromatography (HPLC) technology, to improve accuracy and efficiency in diabetes diagnosis and monitoring. HPLC-based solutions are advanced methods for precisely measuring hemoglobin variants in blood, which helps in monitoring long-term glucose control in diabetic patients. For instance, in June 2021, Trivitron Healthcare Private Limited, an India-based medical technology company, introduced the NANO H5 and NANO H110. The NANO H5 is a compact, automated HPLC analyzer that quantifies glycated hemoglobin (HbA1c) in whole blood with a processing time of 130 seconds, allowing for rapid laboratory results and the capability to process up to five samples simultaneously. The NANO H110 is another compact, automated HPLC analyzer with dual test modes for both HbA1c and Hb Variant detection. It features advanced components such as a barcode scanner and cap piercing, with a high sample capacity of 110, making it suitable for medium to large laboratories.

In January 2024, Roche Holding AG, a Swiss pharmaceutical and diagnostics company, acquired point-of-care (POC) technology from LumiraDx for $350 million. This acquisition aims to expand Roche's diagnostics portfolio and enhance its capabilities in decentralized healthcare settings, providing quick and reliable tests, including the CE-marked HbA1c test, without requiring specialized storage. LumiraDx is a UK-based company specializing in point-of-care (POC) technology and offering immunoassay and clinical chemistry tests for HbA1c.

Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemoglobin A1c (HbA1c) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c (HbA1c) testing market consists of revenues earned by entities by providing services such as home monitoring services, remote patient monitoring solutions, specialized HbA1c assay development, telehealth HbA1c monitoring, and personalized treatment management consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemoglobin A1c (HbA1c) testing market also includes sales of diagnostic reagents, test cartridges, automated analyzers, and calibration standards. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c (HbA1c) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin a1c (hba1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hemoglobin a1c (hba1c) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin a1c (hba1c) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Hemoglobin A1c (HbA1c) Testing Market Characteristics

3. Hemoglobin A1c (HbA1c) Testing Market Trends And Strategies

4. Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hemoglobin A1c (HbA1c) Testing Growth Analysis And Strategic Analysis Framework

6. Hemoglobin A1c (HbA1c) Testing Market Segmentation

7. Hemoglobin A1c (HbA1c) Testing Market Regional And Country Analysis

8. Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market

9. China Hemoglobin A1c (HbA1c) Testing Market

10. India Hemoglobin A1c (HbA1c) Testing Market

11. Japan Hemoglobin A1c (HbA1c) Testing Market

12. Australia Hemoglobin A1c (HbA1c) Testing Market

13. Indonesia Hemoglobin A1c (HbA1c) Testing Market

14. South Korea Hemoglobin A1c (HbA1c) Testing Market

15. Western Europe Hemoglobin A1c (HbA1c) Testing Market

16. UK Hemoglobin A1c (HbA1c) Testing Market

17. Germany Hemoglobin A1c (HbA1c) Testing Market

18. France Hemoglobin A1c (HbA1c) Testing Market

19. Italy Hemoglobin A1c (HbA1c) Testing Market

20. Spain Hemoglobin A1c (HbA1c) Testing Market

21. Eastern Europe Hemoglobin A1c (HbA1c) Testing Market

22. Russia Hemoglobin A1c (HbA1c) Testing Market

23. North America Hemoglobin A1c (HbA1c) Testing Market

24. USA Hemoglobin A1c (HbA1c) Testing Market

25. Canada Hemoglobin A1c (HbA1c) Testing Market

26. South America Hemoglobin A1c (HbA1c) Testing Market

27. Brazil Hemoglobin A1c (HbA1c) Testing Market

28. Middle East Hemoglobin A1c (HbA1c) Testing Market

29. Africa Hemoglobin A1c (HbA1c) Testing Market

30. Hemoglobin A1c (HbA1c) Testing Market Competitive Landscape And Company Profiles

31. Hemoglobin A1c (HbA1c) Testing Market Other Major And Innovative Companies

32. Global Hemoglobin A1c (HbA1c) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin A1c (HbA1c) Testing Market

34. Recent Developments In The Hemoglobin A1c (HbA1c) Testing Market

35. Hemoglobin A1c (HbA1c) Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기